FEVERTREE DRINKS PLC — Board/Management Information 2025

Jan 20, 2025

National Storage Mechanism | Additional information

RNS Number : 8497T

Fevertree Drinks PLC

20 January 2025

20th January 2025

Fevertree Drinks plc

("Fever-Tree" or the "Company")

Appointment Of Corporate Broker

Fever-Tree is pleased to announce the appointment of Jefferies International Limited ("Jefferies") as corporate broker, with immediate effect. Jefferies will act alongside Investec Bank plc and Morgan Stanley & Co. International plc.

Ends

For further information:

Investor queries

Ann Morris-Gibbons, Director of Investor Relations I ann.hyams@fever-tree.com I +44 7435 828 138

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024

Nominated Advisor and Broker - Investec Bank plc

David Flin I +44 (0)20 7597 5970

Corporate Broker - Morgan Stanley & Co. International plc

Andrew Foster I Jessica Pauley I +44 (0)20 7425 8000

Corporate Broker - Jefferies International Limited

Ed Matthews I Richard Taylor I +44 (0)20 7029 8000

Financial PR advisers - FGS Global

Faeth Birch +44 (0)7768 943 171 I Anjali Unnikrishnan +44 (0)7826 534 233

Notes to Editors:

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 95 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

APPUBSBRVAUAAAR